Avience Biomedicals Ltd

Wed 16/09/2026,15:58:50 | NSE : AVIENCE

₹337.45-12.15 (-3.48%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 340.10

Previous Close

₹ 349.60

Volume

37200

Mkt Cap ( ₹ Cr)

₹ 185.09

High

₹ 345.95

Low

₹ 325.00

52 Week High

₹ 414.95

52 Week Low

₹ 222.00

Book Value Per Share

₹ 59.92

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Avience Biomedicals Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

337.45

600

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

600

Option Chain

Analyzes market sentiment, predicts Avience Biomedicals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Avience Biomedicals - Copy of Newspaper Publication

    9 Sep 2026, 10:40AM Avience Biomedicals Limited has informed the Exchange about advertisement of Post dispatch AGM Notice, Copy of Newspaper Publication
  • Avience Biomedicals - Updates

    8 Sep 2026, 11:24PM Avience Biomedicals Limited has informed the Exchange regarding 'The Company has sent Letter to the Shareholder for AGM whose email id is not register
  • Avience Biomedicals - Shareholders meeting

    8 Sep 2026, 12:15PM Avience Biomedicals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026
  • Avience Biomedicals - Updates

    8 Sep 2026, 11:19AM Avience Biomedicals Limited has informed the Exchange regarding 'Avience Biomedicals Limited has informed the Exchange regarding 'Intimation of Annual
  • Avience Biomedicals - Copy of Newspaper Publication

    8 Sep 2026, 7:47AM Avience Biomedicals Limited has informed the Exchange about Copy of Newspaper Publication
  • Avience Biomedicals - Outcome of Board Meeting

    7 Sep 2026, 6:51PM Avience Biomedicals Limited has informed the Exchange regarding Outcome of Board Meeting held on September 07, 2026.
  • Avience Biomedicals - Outcome of Board Meeting

    26 Aug 2026, 12:07AM Avience Biomedicals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
  • Avience Biomedicals - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    29 Jul 2026, 8:42PM Avience Biomedicals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018: Reconciliation o
  • Avience Biomedicals - Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter

    29 Jul 2026, 8:31PM Avience Biomedicals Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q 30 June, 2026 FY 2026-27
  • Avience Biomedicals - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    29 Jul 2026, 8:20PM Avience Biomedicals Limited has informed the Exchange about Certificate in terms of Regulation 74(5) under SEBI (Depositories and Participants) Regula
  • Avience Biomedicals - Analysts/Institutional Investor Meet/Con. Call Updates

    28 Jul 2026, 11:38PM Avience Biomedicals Limited has informed the Exchange about Transcript
  • Avience Biomedicals - Updates

    27 Jul 2026, 2:31PM Avience Biomedicals Limited has informed the Exchange regarding 'AVIENCE Update: Avience Biomedicals Limited has submitted to the Exchange, the financ
  • Avience Biomedicals - Analysts/Institutional Investor Meet/Con. Call Updates

    25 Jul 2026, 4:16PM Avience Biomedicals Limited has informed the Exchange about Link of Recording of con. call held as on 24.07.2026
  • Avience Biomedicals - Investor Presentation

    24 Jul 2026, 1:25PM Avience Biomedicals Limited has informed the Exchange about Investor Presentation
  • Avience Biomedicals - Analysts/Institutional Investor Meet/Con. Call Updates

    21 Jul 2026, 4:28PM Avience Biomedicals Limited has informed the Exchange about Schedule of meet on earning conference call for investors Schedule on July 24 2026 at 04:0
  • Avience Biomedicals has submitted to BSE the Shareholding Pattern for the Period Ended June 24, 2026

    19 Jul 2026, 2:00PM As of June 2026, 64.59% is owned by Indian Promoters and 35.41% by Public. <p align=justify> Institutional holds 12.14% (Insurance Companies 1.17%) an
  • Avience Biomedicals - Outcome of Board Meeting

    17 Jul 2026, 1:56AM Avience Biomedicals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
  • Avience Biomedicals Ltd. debuts with 90.00% premium at Rs 395.20

    25 Jun 2026, 10:10AM Avience Biomedicals Ltd. makes a strong debut on the bourses with scrip got listed at Rs 395.20 on the Bombay Stock Exchange, a 90.00 per cent premium

Key fundamentals

Evaluate the intrinsic value of Avience Biomedicals Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 46.1897 34.2698 13.7845 6.7266 5.2804
Liabilities 46.1897 34.2698 13.7845 6.7266 5.2804
Equity 4.0313 4.0313 3.2845 3.2845 2.0345
Gross Profit 10.9023 7.6519 3.1493 1.425 1.218
Net Profit 6.7333 5.135 1.9838 0.7078 0.7125
Cash From Operating Activities 5.9733 3.202 0.2314 1.5873 -1.9625
NPM(%) 19.06 17.77 12.2 6.48 7.02
Revenue 35.3147 28.8895 16.2551 10.9206 10.1475
Expenses 24.4124 21.2376 13.1058 9.4956 8.9294
ROE(%) 20.48 15.62 6.03 2.15 2.16

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Avience Biomedicals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 860.45 1.00 21.76 0.00 -26.19 0.58
Lotus Eye Hospital and Institute Ltd 114.94 3.93 1642.00 0.00 0.39 0.00
Vaishali Pharma Ltd 8.68 -3.77 27.13 0.00 15.42 0.00
Astec Lifesciences Ltd 661.95 -1.74 0.00 0.00 -363.14 0.00

Company Info

Our Company was incorporated as Avience Biomedicals Private Limited under the provisions of the Companies Act, 2013 vide certificate of incorporation dated December 23,2019, in Delhi. Subsequently, our Company was converted into a Public Limited Company pursuant to shareholders resolution passed at the Extra Ordinary General Meeting of the Company held on June 26, 2024 and the name of our Company was changed from "Avience Biomedicals Private Limited" to "Avience Biomedicals Limited" vide a fresh Certificate of Incorporation dated September 03,2024 having CIN U74999DL2019PLC359158 issued by the Registrar of Companies, Central Processing Centre, Delhi. The registered office of our company is situated at C-11, Block-C, Community Centre, Janakpuri A-3, New Delhi-110058, India.MAJOR EVENTS AND MILESTONES:2022- Inauguration of Noida FactoryA new production facility was established in Noida during the pandemic to support the country in its fight against COVID-19.- Initiated E-Commerce Sales through Government e-Marketplace (GeM) OEMWe were certified as an OEM in GeM and started our e-commerce operations as a result.2023- Tenfold increase in turnover during FY 2021-22We achieved an approximately tenfold growth in turnover in FY 2021-22. In FY 2020-21, the turnover was ?113.30 lakhs, which increased to ?1,014.75 lakhs year over year.- New Manufacturing LicensesWe obtained four manufacturing licenses in FY 2021-22 which are as follows:1. Viral Transport Pack2. Pregnancy Card Pregnancy3. Strips Covid 194. RT PCR Assay2022- New Manufacturing LicensesIn FY 2022-23, we received approval for 10 additional production licenses2023- Allotment of landWe secured an allotment of commercial land measuring 2,100 square meters within the Medical Device Park, located in the Yamuna Expressway Industrial Development Area, at a nominal lease rate. This strategically positioned land offers excellent connectivity to the airport and the expressway, enhancing logistical advantages for operations.- First Export Consignment DispatchedThe first export order has been successfully dispatched in FY 2023-24.- Export Entry into the African Continent - SomaliaThe first export order to Somalia has been successfully completed and Company has entered the African continent.- International Export Registration - EthiopiaWe received approval from the Ethiopian Food and Drug Authority (EFDA) to export our products.- Winning a bid in Andhra Pradesh for ? 82.05 lakhsWe received a large government supply order after winning a bid in Andhra Pradesh for ?82.05/- lakhs.- WHO Good Manufacturing Practice GMP ApprovalThe WHO recognized our manufacturing process as a Good Manufacturing Practice (GMP) for producing quality products that meet international quality standards.- MSME ZED Gold CertificationAs of November 13, 2024, there are only 1515 Zed Gold holders in India, and our company is one of them.- New Manufacturing LicensesIn FY 2023-24, we received approval for 31 new production licenses2024- Laying of the foundation stone for the new factoryLaying the foundation stone for the new large production facility at the Medical Device Park at Yamuna Expressway Industrial Development Area.- Sickle Cell Approval We are one of the few manufacturers in India to receive validation for the sickle cell test from ICMR.- Received the first license for the hematology analyzerWe obtained our first license for manufacturing hematology equipment in FY 2024-25.- Conversion of companyTransitioned to a public company, marking a significant milestone in our growth and expansion.- New Manufacturing LicensesIn FY 2024-25, we received approval for 32 new production licenses2025New Manufacturing LicensesIn FY 2025-26, we received approval for 11 new production licenses2026New Manufacturing LicensesIn FY 2025-26, we received approval for 10 new production licenses

Our Company was incorporated as Avience Biomedicals Private Limited under the provisions of the Companies Act, 2013 vide certificate of incorporation dated December 23,2019, in Delhi. Subsequently, our Company was converted into a Public Limited Company pursuant to shareholders resolution passed at the Extra Ordinary General Meeting of the Company held on June 26, 2024 and the name of our Company was changed from "Avience Biomedicals Private Limited" to "Avience Biomedicals Limited" vide a fresh Certificate of Incorporation dated September 03,2024 having CIN U74999DL2019PLC359158 issued by the Registrar of Companies, Central Processing Centre, Delhi. The registered office of our company is situated at C-11, Block-C, Community Centre, Janakpuri A-3, New Delhi-110058, India.MAJOR EVENTS AND MILESTONES:2022- Inauguration of Noida FactoryA new production facility was established in Noida during the pandemic to support the country in its fight against COVID-19.- Initiated E-Commerce Sales through Government e-Marketplace (GeM) OEMWe were certified as an OEM in GeM and started our e-commerce operations as a result.2023- Tenfold increase in turnover during FY 2021-22We achieved an approximately tenfold growth in turnover in FY 2021-22. In FY 2020-21, the turnover was ?113.30 lakhs, which increased to ?1,014.75 lakhs year over year.- New Manufacturing LicensesWe obtained four manufacturing licenses in FY 2021-22 which are as follows:1. Viral Transport Pack2. Pregnancy Card Pregnancy3. Strips Covid 194. RT PCR Assay2022- New Manufacturing LicensesIn FY 2022-23, we received approval for 10 additional production licenses2023- Allotment of landWe secured an allotment of commercial land measuring 2,100 square meters within the Medical Device Park, located in the Yamuna Expressway Industrial Development Area, at a nominal lease rate. This strategically positioned land offers excellent connectivity to the airport and the expressway, enhancing logistical advantages for operations.- First Export Consignment DispatchedThe first export order has been successfully dispatched in FY 2023-24.- Export Entry into the African Continent - SomaliaThe first export order to Somalia has been successfully completed and Company has entered the African continent.- International Export Registration - EthiopiaWe received approval from the Ethiopian Food and Drug Authority (EFDA) to export our products.- Winning a bid in Andhra Pradesh for ? 82.05 lakhsWe received a large government supply order after winning a bid in Andhra Pradesh for ?82.05/- lakhs.- WHO Good Manufacturing Practice GMP ApprovalThe WHO recognized our manufacturing process as a Good Manufacturing Practice (GMP) for producing quality products that meet international quality standards.- MSME ZED Gold CertificationAs of November 13, 2024, there are only 1515 Zed Gold holders in India, and our company is one of them.- New Manufacturing LicensesIn FY 2023-24, we received approval for 31 new production licenses2024- Laying of the foundation stone for the new factoryLaying the foundation stone for the new large production facility at the Medical Device Park at Yamuna Expressway Industrial Development Area.- Sickle Cell Approval We are one of the few manufacturers in India to receive validation for the sickle cell test from ICMR.- Received the first license for the hematology analyzerWe obtained our first license for manufacturing hematology equipment in FY 2024-25.- Conversion of companyTransitioned to a public company, marking a significant milestone in our growth and expansion.- New Manufacturing LicensesIn FY 2024-25, we received approval for 32 new production licenses2025New Manufacturing LicensesIn FY 2025-26, we received approval for 11 new production licenses2026New Manufacturing LicensesIn FY 2025-26, we received approval for 10 new production licenses

Parent Organisation

Avience Biomedicals Ltd.

Founded

23/12/2019

Managing Director

Mr.Dharam Deo Choudhary

NSE Symbol

AVIENCESM

FAQ